直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Firm
  • Offices
  • Careers
Finnegan
    • Enforcement and Litigation
    • Portfolio and Market Strategy
    • Patent Invalidation Proceedings
    • Trademark and Brand Management
    • Blockchain, NFTs, and Other Digital Assets
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Electronics and Information Technology
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company

Teva Pharmaceuticals International GmbH

Eli Lilly and Company

Representing Eli Lilly in patent litigations involving antibody therapies.

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company, 1:18-cv-12029, D. Mass., Judge Burroughs

Related Professionals

William B. Raich, Ph.D.
Partner
Washington, DC
+1 202 408 4210
Email
Danielle_Duszczyszyn
Danielle A. Duszczyszyn, Ph.D.
Partner
Washington, DC
+1 202 408 4142
Email
Charles T. Collins-Chase
Partner
Washington, DC
+1 202 408 4108
Email
Sydney_Kestle
Sydney R. Kestle
Partner
Washington, DC
+1 202 408 4241
Email
Emily_Gabranski
Emily R. Gabranski
Associate
Washington, DC
+1 202 408 4331
Email
Marta_Garcia
Marta Garcia Daneshvar
Associate
Boston, MA
+1 617 646 1635
Email
Yoonjin_Lee
Yoonjin Lee, Ph.D.
Associate
Washington, DC
+1 202 408 4332
Email
Matthew_Luneack
Matthew J. Luneack
Partner
Washington, DC
+1 202 408 4436
Email

Related Experiences

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company

Eli Lilly and Company

Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.

Eli Lilly and Company

Eli Lilly and Company v. Teva Pharmaceuticals International

Eli Lilly and Company

Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.

Biogen International GmbH

Grünenthal GmbH v. Teva Pharmaceuticals

GrĂ¼nenthal GmbH

When the patent for Zyprexa® and $2 billion in annual revenue were on the line, Eli Lilly turned to Finnegan

Eli Lilly and Company

Eli Lilly and Company v. Actavis Labs. UT Inc.

Eli Lilly and Company

Eli Lilly and Company v. Genentech, Inc.

Eli Lilly and Company

Eli Lilly and Company v. Perrigo Co.

Eli Lilly and Company

Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.

We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.

The Finnegan UPC Hub is a one-stop shop for our insights related to the Unified Patent Court (UPC).

Finnegan
Click Here
  • Privacy
  • Disclaimer
  • EEO Statement

© 2023 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP